# Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding

> **NCT01597531** · PHASE4 · TERMINATED · sponsor: **East Carolina University** · enrollment: 1 (actual)

## Conditions studied

- Type 2 Diabetes
- Gastric Banding

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Orlistat
- **DRUG:** Liraglutide + Orlistat

## Key facts

- **NCT ID:** NCT01597531
- **Lead sponsor:** East Carolina University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Difficulty recruiting patients
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597531, "Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01597531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*